Recently conducted research has investigated the EPH/ephrin pathway for the design of molecularly targeted therapies and novel chemotherapeutic agents to control local tumors and prevent metastatic disease in rhabdomyosarcoma. Here, EPHA1 is linked to metastatic neoplasm.